Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.

Morra, A Schreurs, MAC Andrulis, IL Anton-Culver, H Augustinsson, A Beckmann, MW Behrens, S Bojesen, SE Bolla, MK Brauch, H Broeks, A Patel, AV Peterlongo, P Phillips, K-A Plaseska-Karanfilska, D Polley, EC Presneau, N Pylkäs, K Rack, B Radice, P Rashid, MU Southey, MC Rhenius, V Robson, M Romero, A Saloustros, E Sawyer, EJ Schmutzler, RK Schuetze, S Scott, C Shah, M Smichkoska, S Tapper, WJ Teras, LR Tollenaar, RAEM Tomczyk, K Tomlinson, I Troester, MA Vachon, CM van Veen, EM Wang, Q Buys, SS Wendt, C Wildiers, H Winqvist, R Ziogas, A Hall, P Pharoah, PDP Adank, MA Hollestelle, A Schmidt, MK Hooning, MJ Camp, NJ Castelao, JE Cessna, MH Chang-Claude, J Chung, WK NBCS Collaborators, Colonna, SV Couch, FJ Cox, A Cross, SS Czene, K Daly, MB Dennis, J Devilee, P Dörk, T Dunning, AM Dwek, M Easton, DF Eccles, DM Eriksson, M Evans, DG Fasching, PA Fehm, TN Figueroa, JD Flyger, H Gabrielson, M Gago-Dominguez, M García-Closas, M García-Sáenz, JA Genkinger, J Grassmann, F Gündert, M Hahnen, E Haiman, CA Hamann, U Harrington, PA Hartikainen, JM Hoppe, R Hopper, JL Houlston, RS Howell, A ABCTB Investigators, kConFab Investigators, Jakubowska, A Janni, W Jernström, H John, EM Johnson, N Jones, ME Kristensen, VN Kurian, AW Lambrechts, D Le Marchand, L Lindblom, A Lubiński, J Lux, MP Mannermaa, A Mavroudis, D Mulligan, AM Muranen, TA Nevanlinna, H Nevelsteen, I Neven, P Newman, WG Obi, N Offit, K Olshan, AF Park-Simon, T-W

Abstract: